Skip to content

Clinical trials

Phase 1 Glioma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 1 Country / region: China Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20151
20162
20171
20182
20191
20201
20213
20226
20245
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14
Recruiting9
Not yet recruiting5
Completed4
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tiantan Hospital3
Peking Union Medical College Hospital3
Beijing Biotech2
Xuanwu Hospital, Beijing2
Beijing Bio-Targeting Therapeutics Technology Co., Ltd1
Beijing Neurosurgical Institute1
Beijing Pearl Biotechnology Limited Liability Company1
Cure&Sure Biotech Co., LTD1
Deling Li1
Hebei Senlang Biotechnology Inc., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma35
Glioblastoma10
Brain Neoplasms2
Adenoviridae Infections1
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Diffuse Intrinsic Pontine Glioma1
Medulloblastoma1
Melanoma1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.